Pancreatic Cancer Research

ResearcherNational Institutes of HealthActive in the last 2 years

Chirayu Mohindroo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5825-3356; OpenAlex author ID A5037386730. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  2. New onset diabetes predicts clinical outcomes in patients with pancreatic adenocarcinoma. Co-author DOI 10.21037/jgo-24-570↗
  3. Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2022.05.006↗
  4. The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice. Co-author DOI 10.1016/j.path.2022.05.004↗
  5. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients. Co-author DOI 10.1002/cam4.3870↗
  6. Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cam4.3229↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Florencia M. McAllister · 5 shared papers, 2020–2025 · strength 0.78
  2. Ana De Jesus‐Acosta · 2 shared papers, 2022–2025 · strength 0.45
  3. Arun A. Mavanur · 1 shared paper, 2025 · strength 0.27
  4. Matthew H. G. Katz · 2 shared papers, 2021–2022 · strength 0.23
  5. Michael James Overman · 2 shared papers, 2020–2021 · strength 0.20
  6. Milind M. Javle · 2 shared papers, 2020–2021 · strength 0.20
  7. Jonathan D. Mizrahi · 2 shared papers, 2020–2021 · strength 0.20
  8. Robert A. Wolff · 2 shared papers, 2020–2021 · strength 0.20
  9. Jane Elizabeth Rogers · 2 shared papers, 2020–2021 · strength 0.20
  10. Gauri Rajani Varadhachary · 2 shared papers, 2020–2021 · strength 0.20
  11. David R. Fogelman · 2 shared papers, 2020–2021 · strength 0.20
  12. Shubham Pant · 2 shared papers, 2020–2021 · strength 0.20
  13. Maureen E. Mork · 1 shared paper, 2022 · strength 0.19
  14. Matthew B.B. Yurgelun · 1 shared paper, 2022 · strength 0.19
  15. Anirban Maitra · 1 shared paper, 2022 · strength 0.19
  16. Emma Kurz · 1 shared paper, 2022 · strength 0.12
  17. An Ngo‐Huang · 1 shared paper, 2022 · strength 0.12
  18. Nathan H. Parker · 1 shared paper, 2022 · strength 0.12
  19. Dafna Bar‐Sagi · 1 shared paper, 2022 · strength 0.12
  20. Keri Schadler · 1 shared paper, 2022 · strength 0.12
  21. Sumedha Pareek · 1 shared paper, 2022 · strength 0.12
  22. Maria Q. B. Petzel · 1 shared paper, 2022 · strength 0.12
  23. Rafael Winograd · 1 shared paper, 2022 · strength 0.12
  24. George Miller · 1 shared paper, 2022 · strength 0.12
  25. Laura R. Prakash · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.